Aptamer applications for targeted cancer therapy

Author： Barbas Andrew S   Mi Jing   Clary Bryan M   White Rebekah R  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.7, 2010-07, pp. : 1117-1126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Nanosystems for Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

The contribution of antibodies to targeted cancer therapy

By Apostolou Panagiotis   Papasotiriou Ioannis  

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 258-261

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic cancer — Outlook: targeted therapy

By Michl Patrick   Gress Thomas  

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 2, 2007-04 ,pp. : 176-180

Springer Publishing Company

Access to resources Recommend Favorite

TEM8 Targeted Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 10, 2011-12 ,pp. : 983-992

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes

By              

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1953-1960

Spandidos Publications

Access to resources Recommend Favorite